tyb
*note the none too subtle chi rho/Cairo symbol
>chi rho/Cairo symbol
In 312 A.D., Constantine dreamed he saw a Chi Rho Christogram in the sky and heard the words IN HOC SIGNO ERIS, meaning "In this sign you will be the victor." He ordered the sign of Christ on his legions standards and shields. He won a great victory and later became the first Christian Roman Emperor. He also made Christianity the official religion of the empire.
dem roman emperors
same dietary practices among priest class in both sects
https://www.docdroid.net/Q6S8CEa/air-force-research-objectives-1963-compressed-compressedpdf-pdf
Air Force Research Objectives- 1963
>disease X
Removing the Viral Threat: Two Months to Stop Pandemic X from Taking Hold(2017)
https://www.darpa.mil/news-events/2017-02-06a
DARPA aims to develop an integrated end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in sixty days or less
Over the past several years, DARPA-funded researchers have pioneered RNA vaccine technology, a medical countermeasure against infectious diseases that uses coded genetic constructs to stimulate production of viral proteins in the body, which in turn can trigger a protective antibody response. As a follow-on effort, DARPA funded research into genetic constructs that can directly stimulate production of antibodies in the body.1,2 DARPA is now launching the pandemic Prevention Platform (P3) program, aimed at developing that foundational work into an entire system capable of halting the spread of any viral disease outbreak before it can escalate to pandemic status. Such a capability would offer a stark contrast to the state of the art for developing and deploying traditional vaccines-a process that does not deliver treatments to patients until months, years, or even decades after a viral threat emerges.
"DARPA's goal is to create a technology platform that can place a protective treatment into health providers' hands within 60 days of a pathogen being identified, and have that treatment induce protection in patients within three days of administration. We need to be able to move at this speed considering how quickly outbreaks can get out of control," said Matt Hepburn, the P3 Program Manager. "the technology needs to work on any viral disease, whether it's one humans have faced before or not."
Recent outbreaks of viral infectious diseases such as Zika, H1N1 influenza, and Ebola have cast into sharp relief the inability of the global health system to rapidly contain the spread of a disease using existing tools and procedures. State-of-the-art medical countermeasures typically take many months or even years to develop, produce, distribute, and administer. these solutions often arrive too late-if at all-and in quantities too small to respond to emerging threats. In contrast, the envisioned P3 platform would cut response time to weeks and stay within the window of relevance for containing an outbreak.
Key to this undertaking are nucleic-acid-based technologies-those that are centered on DNA and RNA-including some developed under DARPA's Autonomous Diagnostics to Enable Prevention and therapeutics (ADEPT) program. Using these tools, scientists can identify protective antibodies from recovering patients and then, through a biological version of reverse engineering, manufacture genetic constructs that, when delivered, can instruct an individual's body to produce similar protective antibodies. Significant quantities of these nucleic acid "blueprints" can be rapidly manufactured compared to state-of-the-art antibody production methods.
p1
https://www.darpa.mil/news-events/2017-02-06a
Achieving and integrating breakthroughs in all of these areas will require choreographed cooperation among researchers and engineers specializing in such areas as immunology, microbiology, virology, medical infectious diseases, molecular biology, and medical countermeasure product development and manufacturing.
DARPA-funded teams will be required to demonstrate their integrated platforms in five simulations during the planned four-year program; they will initially test their platforms using pathogens of their choice, but ultimately they will test using DARPA-selected pathogens, including two demonstrations in which the identity of the pathogen will remain opaque to the teams until the 60-day clock starts. To ensure the developed platforms can produce a quality product with a viable pathway for regulatory review, each team will be required to complete a Phase I clinical safety trial before the end of the program.
A benefit of the nucleic-acid-based approach to limiting the spread of infection is that the genetic constructs introduced to the body would be processed quickly and would not integrate into an individual’s genome. Similarly, the antibodies produced in response to the treatment would only be present in the body for weeks to months. This is consistent with DARPA's intent with P3, which is to safely deliver transient immunity to a virus, halting the spread of disease by creating a firewall.
“Our country asks our military Service members to deploy globally and provide humanitarian assistance in all manner of high-risk environments. We owe it to them to develop the best protections possible,” said Hepburn, a U.S. Army physician who previously served as Director of Medical Preparedness on the White House National Security Staff. “If we’re successful, DARPA could take viral infectious disease outbreaks off the table as a threat to U.S. troops and as a driver of global instability.”
To further clarify the P3 program vision, answer questions from potential proposers, and facilitate teaming, DARPA is hosting two identical Proposers Days. The first will be at the Crown Plaza Tysons Corner McLean Hotel in McLean, Va., on February 22, 2017, and the second at the Doubletree by Hilton Hotel San Diego Downtown in San Diego on March 2, 2017. For registration information, visit: http://www.cvent.com/d/9vqy52.
Full details of the P3 program are included in a Broad Agency Announcement, available at: http://go.usa.gov/x9FbG. Proposal abstracts are due by 12:00 PM ET on March 13, 2017. Full proposals are due by 5:00 PM ET on May 1, 2017.
# # #
2 of 2
Pfizer AND Moderna were contracted assets for the US MILITARY via DARPA, aka the DOD and US gov't. In 2013. For mrna bio-nano technology
DARPA Awards Moderna therapeutics A Grant For Up to $25 Million to Develop Messenger RNA therapeutics™ (2013)
https://www.prnewswire.com/news-releases/darpa-awards-moderna-therapeutics-a-grant-for-up-to-25-million-to-develop-messenger-rna-therapeutics-226115821.html
CAMBRIDGE, Mass., Oct. 2, 2013 /PRNewswire/ – Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unknown emerging infectious diseases and engineered biological threats.
Messenger RNA therapeutics™ can be designed to tap directly into the body's natural processes to produce antibodies without exposing people to a weakened or inactivated virus or pathogen, as is the case with the vaccine approaches currently being tested. As a result, Moderna's messenger RNA therapeutics™ platform has the potential to speed the development and manufacture of treatments that can produce a safer, more reliable and more robust immune response than existing technologies.
"We are honored to be chosen by DARPA for this important grant, which will greatly accelerate our efforts to develop antibody messenger RNA therapeutics™ to combat a wide range of infectious diseases," said Stephane Bancel, president and founding CEO of Moderna. "We were awarded this major grant after an intense and rigorous scientific review, and it is a testament to our team's progress and to the profound implications of messenger RNA therapeutics™ that our work was funded. We look forward to further expanding the development of our platform into this critically important new therapeutic area."
This $24.6 million grant could support research for up to 5 years to advance promising antibody- producing drug candidates into preclinical testing and human clinical trials. The company also received a $0.7 million "seedling" grant from DARPA in March to begin work on the project.
This grant is part of a DARPA program called ADEPT: PROTECT (Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious). The goal is to develop platform technologies that can be deployed safely and rapidly to provide the U.S. population with near-immediate protection against emerging infectious diseases and engineered biological weapons, even in cases when the pathogen or infectious agent is unknown.
Pfizer Awarded DARPA Biodefense Contract - DoD Daily Contracts 2013
https://news.clearancejobs.com/2013/12/04/pfizer-awarded-darpa-biodefense-contract-dod-daily-contracts/
Pfizer, Inc., has been awarded a $7,670,632 technology investment agreement. Pfizer shall perform a research and development program designed to develop a technology platform to identify and subsequently induce the production of protective antibodies to an emerging pathogen directly in an infected or exposed individual. Work will be performed in Cambridge, Mass. The estimated completion date is Dec. 8, 2016. Fiscal 2013 research and development funds are being obligated at time of award. The contracting activity is the Defense Advanced Research Projects Agency, Arlington, Va., (HR0011-14-3-0001).
"warp speed". uh huh…
Army General to Co-Lead 'Operation Warp Speed' for COVID-19 Vaccine
https://www.defense.gov/News/News-Stories/Article/Article/2188680/army-general-to-co-lead-operation-warp-speed-for-covid-19-vaccine/
The US Military /US Govt is the culprit.
Either moderna and pfizer failed to deliver on their contractual product delivery obligations, or they built exactly to spec, on contract and on schedule.
How does IT achieve 2 Thessalonians 2:4?
Who opposeth and exalteth himself above all that is called God, or that is worshipped; so that he as Godsitteth in the temple of God, shewing himself that he is God.
You are the temple of god.
1 Corinthians 3:16
Know ye not thatye are the temple of God, and that the Spirit of God dwelleth in you?
WETWARE is how. Neuralink and/ or mrna as reception antennas for "5G and Beyond" signal reception and two-way data transit.
Elon owns TWO wetware companies…
Neuralink
CureVac
ever wonder why the guy who owns a wetware company, Neuralink, also owns an"mrna printing company", Tesla/curevac?
https://electrek.co/2020/11/10/elon-musk-tesla-rna-vaccine-printer-curevac-important-product-world/
https://www.popularmechanics.com/science/a33218172/tesla-patent-curevac-rna-bioreactor-coronavirus/
https://www.reuters.com/article/us-health-coronavirus-tesla-idUSKBN243168
wetware
noun
-
The human central nervous system considered as a computing device or part of a computing device.
-
A human brain or mind as a computing element. Coined as a parallel to hardware and software. Common in the cyberspace genre of science fiction.
-
The underlying generative code for an organism, as found in the genetic material, in the biochemistry of the cells, or in the architecture of the body's tissues.
Wetware computer
A wetware computer is an organic computer composed of organic material "wetware" such as "living" neurons. Wetware computers composed of neurons are different than conventional computers because they use biological materials, and offer the possibility of substantially more energy-efficient computing.
subliminal ukraine flag colors AND a may pole which recalls Beltane and its human sacrificial fertility ritual reenactments…
Who would be the most eye-opening first arrest?
Pope Francis
King Charles
Antonio Gutierres
Augustin Carstens
Bill Gates
Tedros Ghebreyesus
Albert Bourla
Stephen Bancel
Jamie Dimon
George Soros
others?
>The public would NOT find out the truth ever.
According to Q, the truth WILL shock the world. Not would, could, or might, but WILL.
https://qposts.online/?q=truth+will+shock&s=keyword
harris to take the fall, resign?
enter Newsome?
https://www.weforum.org/people/gavin-newsom